Petri Bio

Los Angeles, United States Founded: 2019 • Age: 7 yrs
Microbe-based drugs are manufactured by Petri Bio in biotechnology.

About Petri Bio

Petri Bio is a Healthcare company based in Los Angeles (United States) founded in 2019 by Joseph Schinaman. Microbe-based drugs are manufactured by Petri Bio in biotechnology. The company has 2 employees. Its focus areas include Traditional Pharmaceuticals.

Company details

Petri Bio was founded in 2019 in Los Angeles, United States, with Joseph Schinaman serving as co-founder. Operations are centered on the production of drugs derived from microbes within the biotechnology sector. Manufacturing processes emphasize microbial technologies for pharmaceutical development. The company is headquartered in Los Angeles, and its online presence is maintained through the domain petribio.com. Focus remains on factual advancements in microbe-sourced therapeutics.

  • Headquarters Los Angeles, United States
  • Employees 2
  • Founders Joseph Schinaman
  • Sectors
    Healthcare
  • Website petribio.com
  • Social LinkedIn
Key Metrics
  • Net Profit
    -$49.26 K (USD)
    as on Dec 30, 2020
  • Latest Funding Round
    $1M (USD), Grant

    May 2022

  • Investors
  • Employee Count
    2

Funding Insights of Petri Bio

  • Total Rounds 2
  • Last Round Grant β€” $1M
  • First Round $361,931

    (Sep 2021)

  • Investors Count 1

All 2 funding rounds of Petri Bio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
May 2022$1MGrant––
Sep 2021$361,931Grant––
Valuation history

1 investors in total: 1 institutional.

Investors in Petri Bio

Petri Bio has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Public health and human services are overseen by HHS.
1953hhs.gov
Premium access

Investor details for Petri Bio

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Petri Bio

2 people are tracked at Petri Bio (2 in leadership); the tracked headcount is 2.

NameRoleGroup
Joseph Schinaman
Co-FounderLeadership
Shu Li
Co-Founder and CEOLeadership
Premium access

Complete people profiles for Petri Bio

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Petri Bio

3 dated milestones of Petri Bio across 3 years, from founding to its latest funding, stage changes and deals.

  1. Founded Petri Bio is founded.
  2. Funding First funding round of $362K.
  3. Funding Latest funding round, Grant, of $1.0M.

Top companies in Traditional Health & Nutrition

3 companies that operate in the same segment as Petri Bio (Traditional Health & Nutrition) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Manufacturer of generics formulations
2002Bridgewater, New Jersey, United StatesUSD 3.02 B8,300
Biosimilar therapeutics are developed for oncology and autoimmune diseases.
2010Redwood City, California, United StatesUSD 143.62 MUSD 42.17 M228
Ophthalmic pharmaceuticals and instruments are developed for eye care.
1853Bridgewater, New Jersey, United StatesUSD 5.1 B13,500
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Petri Bio

Petri Bio was founded in 2019 and raised its 1st funding round 2 years after it was founded.

Petri Bio is headquartered in Los Angeles, United States. It is registered at Los Angeles, California, United States.

Petri Bio has 2 employees.

Petri Bio was founded in 2019 in Los Angeles, United States, with Joseph Schinaman serving as co-founder. Operations are centered on the production of drugs derived from microbes within the biotechnology sector. Manufacturing processes emphasize microbial technologies for pharmaceutical development. The company is headquartered in Los Angeles, and its online presence is maintained through the domain petribio.com. Focus remains on factual advancements in microbe-sourced therapeutics.

Petri Bio has 1 investor. Key investors include HHS.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available